RETROPERITONEAL FIBROSIS AND TREATMENT OF PARKINSONS-DISEASE WITH HIGH-DOSES OF BROMOCRIPTINE

被引:34
作者
DEMONET, JF
ROSTIN, M
DUEYMES, JM
IOUALALEN, A
MONTASTRUC, JL
RASCOL, A
机构
[1] CHU PURPAN,FAC MED,SERV PHARMACOL MED & CLIN,37 ALLEES JULES GUESDE,F-31000 TOULOUSE,FRANCE
[2] CHU RANGUEIL,SERV UROL,F-31054 TOULOUSE,FRANCE
[3] CHU PURPAN,CTR MIDI PYRENEES PHARMACOVIGILANCE & INFORMAT MEDICAMENT,F-31000 TOULOUSE,FRANCE
[4] CHU PURPAN,SERV NEUROL,TOULOUSE,FRANCE
[5] CHU PURPAN,SERV NEPHROL,TOULOUSE,FRANCE
关键词
D O I
10.1097/00002826-198604000-00012
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:200 / 201
页数:2
相关论文
共 6 条
[1]  
[Anonymous], 1978, HDB EXPT PHARM
[2]  
LEWITT PA, 1981, LANCET, V1, P44
[3]   SHOULD DOPAMINE AGONISTS BE GIVEN EARLY OR LATE IN THE TREATMENT OF PARKINSONS-DISEASE [J].
RASCOL, A ;
MONTASTRUC, JL ;
RASCOL, O .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1984, 11 (01) :229-232
[4]  
RINNE UK, 1981, LANCET, V1, P44
[5]  
ROBERT M, 1984, NEW ENGL J MED, V311, P601
[6]  
RONDOT P, 1984, SEM HOP PARIS, V60, P2817